4.8 Article

Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants

期刊

CIRCULATION
卷 144, 期 20, 页码 1600-1611

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.121.053521

关键词

arrhythmogenic right ventricular dysplasia; death; sudden; cardiac; FLNC protein; human; heart failure; outcome studies; prognosis

资金

  1. National Institutes of Health (NIH) [R01HL69071, R01HL116906, R01HL147064]
  2. America Heart Association (AHA) [17GRNT33670495]
  3. NIH [1K23HI067915, 2UM1HG006542, R01HL109209, K08 HL143185, U01HG007708, 1U24EB023674]
  4. CRTrieste Foundation
  5. Cassa di Risparmio of Gorizia Foundation
  6. Fondation Leducq [14-CVD03]
  7. NIH/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards [UL1 TR002535, UL1 TR001082]
  8. Netherlands Cardiovascular Research Initiative
  9. Dutch Heart Foundation [CVON2015-12/2018-30 eDETECT/PREDICT2, 2015T058]
  10. UMC Utrecht Fellowship Clinical Research Talent
  11. Leonie-Wild Foundation
  12. Francis P. Chiaramonte Private Foundation
  13. Leyla Erkan Family Fund for ARVD Research
  14. Dr. Satish, Rupal, and Robin Shah ARVD Fund at Johns Hopkins
  15. Bogle Foundation
  16. Healing Hearts Foundation
  17. Campanella family
  18. Patrick J. Harrison Family
  19. Peter French Memorial Foundation
  20. Wilmerding Endowments
  21. John Taylor Babbitt Foundation
  22. Sarnoff Cardiovascular Research Foundation
  23. Victor Chang Cardiac Research Institute
  24. National Health and Medical Research Council
  25. Estate of the Late RT Hall
  26. O'Hare Family Foundation

向作者/读者索取更多资源

This study found that arrhythmogenic cardiomyopathy caused by FLNCtv is phenotypically heterogeneous and characterized by a high risk of life-threatening arrhythmias, which does not seem to be associated with the severity of left ventricular dysfunction.
Background: Filamin C truncating variants (FLNCtv) cause a form of arrhythmogenic cardiomyopathy: the mode of presentation, natural history, and risk stratification of FLNCtv remain incompletely explored. We aimed to develop a risk profile for refractory heart failure and life-threatening arrhythmias in a multicenter cohort of FLNCtv carriers. Methods:FLNCtv carriers were identified from 10 tertiary care centers for genetic cardiomyopathies. Clinical and outcome data were compiled. Composite outcomes were all-cause mortality/heart transplantation/left ventricle assist device (D/HT/LVAD), nonarrhythmic death/HT/LVAD, and sudden cardiac death/major ventricular arrhythmias. Previously established cohorts of 46 patients with LMNA and 60 with DSP-related arrhythmogenic cardiomyopathies were used for prognostic comparison. Results: Eighty-five patients carrying FLNCtv were included (4215 years, 53% men, 45% probands). Phenotypes were heterogeneous at presentation: 49% dilated cardiomyopathy, 25% arrhythmogenic left dominant cardiomyopathy, 3% arrhythmogenic right ventricular cardiomyopathy. Left ventricular ejection fraction was <50% in 64% of carriers and 34% had right ventricular fractional area changes (RVFAC=(right ventricular end-diastolic area - right ventricular end-systolic area)/right ventricular end-diastolic area) <35%. During follow-up (median time 61 months), 19 (22%) carriers experienced D/HT/LVAD, 13 (15%) experienced nonarrhythmic death/HT/LVAD, and 23 (27%) experienced sudden cardiac death/major ventricular arrhythmias. The sudden cardiac death/major ventricular arrhythmias incidence of FLNCtv carriers did not significantly differ from LMNA carriers and DSP carriers. In FLNCtv carriers, left ventricular ejection fraction was associated with the risk of D/HT/LVAD and nonarrhythmic death/HT/LVAD. Conclusions: Among patients referred to tertiary referral centers, FLNCtv arrhythmogenic cardiomyopathy is phenotypically heterogeneous and characterized by a high risk of life-threatening arrhythmias, which does not seem to be associated with the severity of left ventricular dysfunction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据